Placeholder text

Go to cart

Synthesis and antitumor evaluation of new heterocyclic systems

By Islavathu Hatti

Synthesis and antitumor evaluation of new heterocyclic systems Natural Sciences

Synthesis and antitumor evaluation of new heterocyclic systems

0 - Default Title
Description
Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Cancer is a leading cause of death worldwide. In 2012 about 14.1 million new cases of cancer occurred globally and it caused about 8.2 million deaths or 14.6 % of human deaths. There is much more necessity to design and synthesize the most potent anticancer agents for cancer chemotherapy. It is most important that synthesized compounds do not show any activity on the normal human embryonic kidney cells, HEK-293. These type of compounds only can act as valuable drugs for cancer disease to the future generations. In future, some novel therapies were also used for the inhibition of cancer cell lines. Despite the introduction of new anticancer drugs, such as antimetabolites (capecitabine) and topoisomerase I inhibitors, the management of advanced neck cancer remains challenging. During the past years, interest has focused more on novel agents with a more targeted mechanism of the action. Targeted therapy aims to specifically act on a well defined target or biologic pathway that, when inactivated, causes regression or distraction of the malignant process.
Product details
Binding:
Paperback
Number of Pages:
208
Release Date:
2025-11-03
Publication Date:
2025-11-03
Publisher:
LAP LAMBERT Academic Publishing
Languages:
Original: English
ISBN10:
6209185347
ISBN13:
9786209185342
Weight:
328 g
Height:
150 cm
Width:
220 cm
Thickness:
13 cm
Buy on Amazon
Currently sold out